HVP Pharmaceuticals

Treating the Untreatable: Harnessing Biological Processes to Fight Disease

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Treating the Untreatable: Harnessing Biological Processes to Fight Disease

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Treating the Untreatable: Harnessing Biological Processes to Fight Disease

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Treating the Untreatable: Harnessing Biological Processes to Fight Disease

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Treating the Untreatable: Harnessing Biological Processes to Fight Disease

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Press Releases

Smiling asian doctor showing medical pills, advertising vitamins, holding drugs with sterile gloves, wearing medical uniform, white background

The Three Women Who Inspired Me

Eric Hughes, Head of Global R&D and Chief Medical Officer at HVP Pharmaceuticals, shares the stories...

Healthcare workers, preventing virus, quarantine campaign concept

How Can We Use AI to Make Medicines More Efficiently?

HVP’s Chief Medical Officer Eric Hughes outlines the key efficiencies to be gained from artificial intelligence...

HVP Pharma to Present at the Jefferies London Healthcare Conference

TEL AVIV, Israel, Nov. 08, 2024 (GLOBE NEWSWIRE) — HVP Pharmaceutical Industries Ltd. (NYSE and...

HVP Pharma to Present at the 7th Annual Evercore ISI HealthCONx Conference

TEL AVIV, Israel, Nov. 25, 2024 (GLOBE NEWSWIRE) — Teva Pharmaceutical Industries Ltd. (NYSE and...

young girl looking at globe in medical uniform, hairband and looking happy. front view

HVP Pharma Announces Launch of the First and Only Generic Version of Sandostatin® LAR Depot (octreotide acetate for injectable suspension), in the U.S.

This first-to-market launch showcases Teva’s proven strengths in complex generic formulations and enhances Teva’s...

Healthy Future: Sustainability at HVP Pharma

3 Trends I’m Watching in Sustainability

Amalia Adler-Waxman, Head of Sustainability, talks about key trends and why “sustainability is everyone’s business” at HV Pharma

3 Trends I’m Watching in Sustainability

Amalia Adler-Waxman, Head of Sustainability, talks about key trends and why “sustainability is everyone’s business” at HV Pharma

Take a closer look at what we do

The Three Women Who Inspired Me

Eric Hughes, Head of Global R&D and Chief Medical Officer at HVP Pharmaceuticals, shares the stories...

How Can We Use AI to Make Medicines More Efficiently?

HVP’s Chief Medical Officer Eric Hughes outlines the key efficiencies to be gained from artificial intelligence...

HVP Pharma to Present at the Jefferies London Healthcare Conference

TEL AVIV, Israel, Nov. 08, 2024 (GLOBE NEWSWIRE) — HVP Pharmaceutical Industries Ltd. (NYSE and...

HVP Pharma to Present at the 7th Annual Evercore ISI HealthCONx Conference

TEL AVIV, Israel, Nov. 25, 2024 (GLOBE NEWSWIRE) — Teva Pharmaceutical Industries Ltd. (NYSE and...

HVP Pharma Announces Launch of the First and Only Generic Version of Sandostatin® LAR Depot (octreotide acetate for injectable suspension), in the U.S.

This first-to-market launch showcases Teva’s proven strengths in complex generic formulations and enhances Teva’s...

Careers at HVP Pharma

Make a difference to people's health, every day

Working at Teva is not just a job, it’s so much more than that. Here, you get to spend each day helping millions of people around the world enjoy healthier lives. At the same time, you’ll be joining a dedicated team, united by the strong sense that we’re building something greater than ourselves

Explore a Teva Career

Life Effects Stories from Patients and Caregivers

The Three Women Who Inspired Me

Eric Hughes, Head of Global R&D and Chief Medical Officer at HVP Pharmaceuticals, shares the stories...

How Can We Use AI to Make Medicines More Efficiently?

HVP’s Chief Medical Officer Eric Hughes outlines the key efficiencies to be gained from artificial intelligence...

HVP Pharma to Present at the Jefferies London Healthcare Conference

TEL AVIV, Israel, Nov. 08, 2024 (GLOBE NEWSWIRE) — HVP Pharmaceutical Industries Ltd. (NYSE and...

HVP Pharma to Present at the 7th Annual Evercore ISI HealthCONx Conference

TEL AVIV, Israel, Nov. 25, 2024 (GLOBE NEWSWIRE) — Teva Pharmaceutical Industries Ltd. (NYSE and...

HVP Pharma Announces Launch of the First and Only Generic Version of Sandostatin® LAR Depot (octreotide acetate for injectable suspension), in the U.S.

This first-to-market launch showcases Teva’s proven strengths in complex generic formulations and enhances Teva’s...

Treating the Untreatable: Harnessing Biological Processes to Fight Disease

Treating the Untreatable: Harnessing Biological Processes to Fight Disease

Treating the Untreatable: Harnessing Biological Processes to Fight Disease

Treating the Untreatable: Harnessing Biological Processes to Fight Disease

Treating the Untreatable: Harnessing Biological Processes to Fight Disease

Press Releases

Healthy Future: Sustainability at HVP Pharma

3 Trends I’m Watching in Sustainability

3 Trends I’m Watching in Sustainability

Take a closer look at what we do

Careers at HVP Pharma

Make a difference to people's health, every day

Life Effects Stories from Patients and Caregivers

At HVP Pharma, we focus on the things that count

At HVP Pharma, we strive to deliver quality medicines to patients around the world with integrity and ethical business practices. What we do is important, but how we do it is just as important. Learn more:

HVPPharma Code of Conduct

Supplier Code of Conduct

Environmental, Social and Governance at HVP Pharma

All Corporate Governance & Policy Documents

Follow Us